Alternative Careers in the Pharmaceutical and Biotechnology Industry

Download Report

Transcript Alternative Careers in the Pharmaceutical and Biotechnology Industry

Alternative Careers in the
Pharmaceutical and Biotechnology
Industry
Martin A. Wasserman, Ph.D.
January 14, 2014
UTMB Career Development Workshop
TOP PHARMA/BIOTECH COMPANIES
•
Pfizer
•
Merck
•
GlaxoSmithKline (GSK)
•
Novartis
•
Bristol-Myers Squibb (BMS)
•
Hoffmann-La Roche (Roche)
•
Eli Lilly
•
Abbott
•
Sanofi
•
Amgen, Genentech, Biogen
THE WORLD IS CHANGING…
AND SO MUST WE
• Pharmaceutical and biotechnology company M&A are
increasing competitive pressure, e.g., Sanofi, GSK, Merck,
Pfizer, Novartis, BMS, AZ, HLR
• Industry trends require key decision points, e.g., milestones and
Go/No Go criteria
• R&D expenditures have dramatically increased
• Longer cycle times across the value chain
• Generics have initiated price pressures
• Globalization of markets
THE PHARMA AND BIOTECH INDUSTRY
•
Americans spend > $320B/year on medicines
•
For-profit, highly government-regulated business which
innovatively discovers, tests, manufactures, and distributes a
wide range of novel, safe, effective and quality-controlled
medicines to prevent, treat and cure human diseases (a noble
profession)
•
Technically complex, risky, costly, and regulated industry
•
Creates jobs (employs > 300,000 workers WW) and invests
billions in R&D
•
Takes risks on unknown opportunities for potential “breakthrough
blockbusters”; highly rewarding
•
Orchestrates project progression across the Value Chain
INDUSTRY VS. ACADEMIA
• Less differences and more similarities
• Long hours and much is expected
• Expectations to advance science, innovation, and to foster career
growth are similar; personal accountability
• Novelty and scientific freedom are encouraged
• Mentors and supervisors encourage collegiality (“Team
Membership”), consistent productivity, and communication
• Regular feedback on performance
• Job security linked to performance and funding
• “Publish or perish” pertains to both
• Flexibility and adaptability are imperative in the industry; expect
and conform to change
PHARMACEUTICAL INDUSTRY
MYTHS AND MISCONCEPTIONS
•
PhDs and MDs inferior to academic counterparts
•
No publishing or meeting presentations required
•
Only perform work as instructed by supervisors
•
No academic adjunct appointments or external
collaborations permitted
•
Keep breakthrough ideas to yourself
•
No novel proposal (“grant”) writing expected
•
Unlimited funds to do everything
•
No opportunities to transfer to non-bench jobs
PHARMACEUTICAL INNOVATION
•
Assessed at time of Market introduction
•
Efficacy for a disease for which no drug is presently available
•
Novelty is competitive and time-related
•
Means “truly original”…not yet reduced to practice
•
Should improve the practice of medicine
•
Discovery of new approaches (Scientific Innovation), improves
QoL or convenience for the patient, or improved formulations
•
Needs to be critically reassessed at each stage of the
Development Process
DISCOVERY RESEARCH
MISSION AND STRATEGY
• To rapidly discover novel, innovative, breakthrough drug candidates
to treat diseases using cutting-edge technologies
• To utilize early exploratory efforts to identify novel targets
• To utilize state-of-the-art assay formats to identify “hits and leads”
• Wherever possible, leverage “common mechanism” approaches to be
opportunistic and synergistic to increase productivity and to reduce
cycle time in pursuing a diverse set of targets
• To recognize failing compounds EARLY (“kill early, kill often”) and
conduct quick “proof-of-concept” studies
THE DISCOVERY PROCESS
Toxicogenomics
Chemical
Genomics
Evaluation of
Lead Drug
Candidates
Manufacturing
Development
Pharmacogenomics
Actives, Hits,
Functional
Genomics
Lead Compounds
Target
Identification
& Validation
Evaluation of
drug efficacy
Assay
Development
PK
Safety
HTS
Genomic
research
Gene sequencing
Microarrays
Proteomics
3
4
Clinical Trials
Process
Development
Quality
Control
Medicinal
Chemistry
Establish role of
gene in biology
and disease
Manufacturing
5
2
6
Clinical
Evaluation
(safety, efficacy)
and new drug
application
NDA
Launch
1
Personalized
Medicine
SIGNIFICANT ADVANCES
IN DRUG DESIGN
• Identification of new molecular targets
• Cloning of human receptors, enzymes, ion channels for
structural elucidation of binding sites
• Structural analysis of drugs with their binding sites, e.g., X-ray
crystallography, NMR
• Proprietary libraries of >107 chemical structures
• Combinatorial chemistry techniques for rapid synthesis of
selected drugs and related analogues
• Automated HTPS for SAR (>105 compounds/week)
REASONS DRUG CANDIDATES FAIL
IN CLINICAL DEVELOPMENT
• Toxicity- 2%
• Lack of efficacy- 31%
• The market- 6%
• Poor biopharmaceutical properties, e.g., formulation,
pharmacokinetics, ADME- 41%
Note: For every 20 compounds entering Phase I clinical
trials, only 1 may become a marketed drug!
KEY VALUES AND
OPERATING PRINCIPLES
•
Urgency (focus on priorities, speedy delivery, flexibility, problem solving)
•
Creativity (innovation, originality, new hypotheses & targets, thinking “out-of-the-box”)
•
Courage (tenacity, decisiveness, tough decisions)
•
Empowerment (personal accountability; responsibility)
•
Teamwork (networking, partnership, sharing information, interactive)
•
Integrity (ethical standards, honesty & fairness)
•
Respect (trust, openness, listening, value diversity)
WHAT COMPANIES LOOK FOR
Candidates who:
• Are driven and motivated
• Are ambitious
• Are risk takers
• Can follow instructions and take directions
• Can work independently and as a Team Member
• Can cope with stress and failure
• Have the ability to manage and resolve conflict
SOME CORE SKILLS IN THE
PHARMACEUTICAL INDUSTRY
•
•
•
•
•
•
•
•
•
•
•
•
Pharmacology, Anatomy & Physiology
Molecular and Cellular Immunology, Genomics
Cellular and Molecular Biology
Biochemistry and Enzymology
Pathology & Toxicology
Animal Model Development, Drug Delivery, Formulations
Medicinal, Combinatorial, Analytical, Process Chemistry
ADME, Pharmacokinetics
Biostatistics, Statistical Analysis
Scientific & Medical Intelligence, Communication
Data & Knowledge Management
Networking, Opportunity Identification
REQUISITE COMMUNICATION SKILLS
Verbal Presentations:
•
Authoritative and Persuasive
•
Team, Department, and Corporate
•
National and International Meetings,
Conferences, and Symposia
Written Publications:
•
Internal Technical and Final Reports
•
Abstracts and Peer-Reviewed Manuscripts
•
Invited Reviews and Book Chapters
•
Research Feasibility Proposals (“Grants”)
DIVERSE CAREER OPPORTUNITIES I
• Drug Discovery and Design; Innovation Strategy and
Implementation
• Preclinical Research and Biomarker Development
• Patents, Intellectual Property (IP)
• Non-Clinical Analytical ADME (DMPK)
• Pathology & Toxicology
• Clinical Pharmacology
• Clinical Trial Design and Data Management
• Business Development
• Licensing, Alliance Management (JVs), M&A
• Medical Writing and Medical Communication
DIVERSE CAREER OPPORTUNITIES II
• Lab Automation
• Product Formulation and Drug Delivery
• Biostatistics
• Scientific, Clinical, Medical Affairs
• Medical Science Liaison (MSL); Identify KOLs
• Competitive Medical & Scientific Intelligence
• Technology Transfer; Identify & Interact with CROs
• Regulatory Affairs Worldwide, e.g., FDA
• Drug Safety (Pharmacovigilence)
• QA/QC; Manufacturing; Process Development
INTERVIEWING TIPS FOR SUCCESS
• Prepare, Prepare, Prepare
• Research the Company and the Key Players
• Be Aware of Your Strengths and Weaknesses
• Differentiate Yourself, e.g., Experience, Expertise, and
Accomplishments
• Demonstrate Evidence That You Meet the Job Specs
• Focus on Quantifiable, Specific Actions & Results
• Tailor Responses to the Job Opportunity
• Show Interest and Enthusiasm
• Demonstrate Likability and Competency
SUMMARY
• Role, mission and strategy of the industry
• Complex, risky, costly, highly-regulated industry
• Are there differences from an academic career?
• Put to rest common myths and misconceptions
• Cutting-edge drug design technological advances
• Industry values and operating principles
• Potential candidates and core skills
• Diversity of career opportunities in the industry
• Richly rewarding noble profession!